Thus, altered insulin signaling may modulate GSK‐3β activity, leading to the hyperphosphorylated state of tau proteins observed in the brains of patients with T2DM (Frazier et al., 2019). The gene discussed is MAPT; the disease is type 2 diabetes mellitus.